BAILEY SHUNYAKOV: Open Payments
NPI 1912560038 · BOLIVAR, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$7,713 in 180 payments from 39 companies in 2025. Trend: 2023 $4,222 · 2024 $6,758 · 2025 $7,713
Food & beverage: $3,823Consulting: $3,812Education: $78
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 9 | $3,969 |
| AstraZeneca Pharmaceuticals LP | 20 | $551 |
| ABBVIE INC. | 13 | $391 |
| Celgene Corporation | 13 | $190 |
| E.R. Squibb & Sons, L.L.C. | 13 | $180 |
| Regeneron Healthcare Solutions, Inc. | 6 | $172 |
| PFIZER INC. | 14 | $170 |
| Janssen Biotech, Inc. | 10 | $166 |
| Merck Sharp & Dohme LLC | 7 | $163 |
| Novartis Pharmaceuticals Corporation | 9 | $162 |
Products named: Enhertu, DATROWAY, REBLOZYL, KEYTRUDA, LIBTAYO, IMBRUVICA, IMDELLTRA (AMG757), MI CANCER SEEK.
Industry payments across MO — which companies pay providers there.
